Patients with nodding syndrome in Uganda improve with symptomatic treatment: a cross-sectional study.
Patients with nodding syndrome in Uganda improve with symptomatic treatment: a cross-sectional study.
复制标题
DOI：
10.1136/bmjopen-2014-006476
复制
发表时间：
2014-11-14
期刊：
影响因子：
2.9
通讯作者：
Opar BT
中科院分区：
文献类型：
--
作者：
Idro R;Namusoke H;Abbo C;Mutamba BB;Kakooza-Mwesige A;Opoka RO;Musubire AK;Mwaka AD;Opar BT
Nodding syndrome (NS) is a poorly understood neurological disorder affecting thousands of children in Africa. In March 2012, we introduced a treatment intervention that aimed to provide symptomatic relief. This intervention included sodium valproate for seizures, management of behaviour and emotional difficulties, nutritional therapy and physical rehabilitation. We assessed the clinical and functional outcomes of this intervention after 12 months of implementation. This was a cross-sectional study of a cohort of patients with NS receiving the specified intervention. We abstracted preintervention features from records and compared these with the current clinical status. We performed similar assessments on a cohort of patients with other convulsive epilepsies (OCE) and compared the outcomes of the two groups. Participants were patients with WHO-defined NS and patients with OCE attending the same centres. The primary outcome was the proportion of patients with seizure freedom (≥1 month without seizures). Secondary outcome measures included a reduction in seizure frequency, resolution of behaviour and emotional difficulties, and independence in basic self-care. Patients with NS had had a longer duration of symptoms (median 5 (IQR 3, 6) years) compared with those with OCE (4 (IQR 2, 6) years), p<0.001. The intervention resulted in marked improvements in both groups; compared to the preintervention state, 121/484 (25%) patients with NS achieved seizure freedom and there was a >70% reduction in seizure frequency; behaviour and emotional difficulties resolved in 194/327 (59%) patients; 193/484 (40%) patients had enrolled in school including 17.7% who had earlier withdrawn due to severe seizures, and over 80% had achieved independence in basic self-care. These improvements were, however, less than that in patients with OCE of whom 243/476 (51.1%) patients were seizure free and in whom the seizure frequency had reduced by 86%. Ugandan children with NS show substantial clinical and functional improvements with symptomatic treatments suggesting that NS is probably a reversible encephalopathy.
登录
查看更多内容
影响因子：
2.9
作者：
Idro R;Opoka RO;Aanyu HT;Kakooza-Mwesige A;Piloya-Were T;Namusoke H;Musoke SB;Nalugya J;Bangirana P;Mwaka AD;White S;Chong K;Atai-Omoruto AD;Mworozi E;Nankunda J;Kiguli S;Aceng JR;Tumwine JK
通讯作者：
Tumwine JK
影响因子：
1
作者：
Idro, R.;Musubire, K. A.;Mbonye, A. K.
通讯作者：
Mbonye, A. K.
影响因子：
1
作者：
Tumwine, J. K.;Vandemaele, K.;Spencer, P. S.
通讯作者：
Spencer, P. S.
影响因子：
3.7
作者：
Foltz JL;Makumbi I;Sejvar JJ;Malimbo M;Ndyomugyenyi R;Atai-Omoruto AD;Alexander LN;Abang B;Melstrom P;Kakooza AM;Olara D;Downing RG;Nutman TB;Dowell SF;Lwamafa DK
通讯作者：
Lwamafa DK
影响因子：
5.6
作者：
Berg, AT;Shinnar, S;Ebrahimi, N
通讯作者：
Ebrahimi, N